Home/Filings/4/0001209191-23-046276
4//SEC Filing

Anand Bhaskar 4

Accession 0001209191-23-046276

CIK 0001358762other

Filed

Aug 16, 8:00 PM ET

Accepted

Aug 17, 4:31 PM ET

Size

6.3 KB

Accession

0001209191-23-046276

Insider Transaction Report

Form 4
Period: 2023-08-15
Anand Bhaskar
VP, Chief Accounting Officer
Transactions
  • Sale

    Class A common stock

    2023-08-15$169.06/sh193$32,62824,705 total
  • Sale

    Class A common stock

    2023-08-16$168.42/sh210$35,36824,495 total
Footnotes (1)
  • [F1]The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.

Issuer

REATA PHARMACEUTICALS INC

CIK 0001358762

Entity typeother

Related Parties

1
  • filerCIK 0001890784

Filing Metadata

Form type
4
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:31 PM ET
Size
6.3 KB